Bankruptcy Settlement Plan Needs To Be Upheld, Purdue Pharma Tells High Court
WASHINGTON, D.C. — The U.S. Supreme Court should affirm the Second Circuit U.S. Court of Appeals’ approval of a multibillion-dollar Purdue Pharma LP opioid bankruptcy settlement that included a liability release...To view the full article, register now.
Already a subscriber? Click here to view full article